¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Polymorphism, Restriction Fragment Length"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
restriction fragment length polymorphism
Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
polymorphism
´ÙÇüÅÂ, ¹µÇüÅÂ, ¿©·¯ÇüÅÂ
single nucleotide polymorphism
´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
acentric fragment
¹«Áß½ÉÀýÁ¶°¢, ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
asymmetric fetal growth restriction
ºñ´ëĪžƼºÀåÁ¦ÇÑ
bone fragment
»ÄÁ¶°¢, °ñÆí
Fc fragment
FcºÐÀý
fallen fragment sign
³«ÇÏÆÄÆí¡ÈÄ
fracture fragment
°ñÀýÁ¶°¢, °ñÀýÀýÆí
fragment
Á¶°¢, Æí
genetic restriction
À¯Àü»óÈ£ÀÛ¿ëÁ¦ÇÑ
intrauterine growth restriction
Àڱ󻼺ÀåÁ¦ÇÑ
restriction
Á¦ÇÑ
restriction endonuclease
Á¦ÇÑÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑ¿£µµ´ºÅ¬·¹¾ÆÁ¦
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
10
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
length
±æÀÌ
polymorphism
´ÙÇüÅÂ, ¿©·¯ÇüÅÂÁõ
fragment
Á¶°¢
bone fragment
»ÄÁ¶°¢
restriction enzyme
Á¦ÇÑÈ¿¼Ò
restriction map
Á¦ÇÑÈ¿¼ÒÁöµµ
restriction
Á¦ÇÑ
intrauterine growth restriction
Àڱ󻼺ÀåÁö¿¬
salt restriction
¿°ºÐÁ¦ÇÑ
water restriction
¹°Á¦ÇÑ, ¼öºÐÁ¦ÇÑ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
restriction fragment length polymorphism
Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
polymorphism
´ÙÇüÅÂ, ¿©·¯ÇüÅÂÁõ
acentric fragment
¹«Áß½ÉÀýÁ¶°¢, ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
bone fragment
»ÀÁ¶°¢, °ñÆí
fragment
Á¶°¢
fallen fragment sign
³«ÇÏÆÄÆí¡ÈÄ
fracture fragment
°ñÀýÁ¶°¢, °ñÀýÀýÆí
restriction endonuclease
Á¦ÇÑÀûÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑÀû¿£µµ´ºÅ¬·¹¾ÆÁ¦
restriction enzyme
Á¦ÇÑÈ¿¼Ò
genetic restriction
À¯ÀüÀû»óÈ£ÀÛ¿ëÁ¦ÇÑ
haplotype restriction
ÀϹè¼öüÁ¦ÇÑ
restriction map
Á¦ÇÑÈ¿¼ÒÁöµµ
restriction
Á¦ÇÑ
restriction endonuclease
Á¦ÇÑÇٻ곻ºÎ°¡¼öºÐÇØÈ¿¼Ò
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
Ia restriction
IaÂ÷À̼ö¹Ý ¸é¿ª»óÈ£ÀÛ¿ëÁ¦ÇÑ
haplotype restriction
ÁÖÁ¶Á÷ÀûÇÕÇ׿øº¹ÇÕü¿°»öü Â÷À̼ö¹Ý ¸é¿ªÁ¦ÇÑ
homologous restriction factor
µ¿Á¾Á¦ÇÑÀÎÀÚ
DNA polymorphism
DNA ´ÙÇü¼º
polymorphism
´ÙÇüÁõ
polymorphism
´ÙÇüÁõ(Òýû¡à÷ñø)
polymorphism
´ÙÇü¼ºÁõ
polymorphism
´ÙÇü, ´ÙÇüÅÂ
polymorphism
´ÙÇü¼º(Òýû¡à÷), ´ÙÇüÇö»ó(Òýû¡úÞßÚ)
polymorphism
´ÙÇü¼º(Òýúþàõ)
F(ab) fragment
F(ab)Á¶°¢
Fab fragment
Fab ºÐÀý.
Fab fragment
Fab Á¶°¢.
Fab fragment
Fab ºÐÀý
Length constant
±æÀÌÁö¼ö(¡ò¦â¦)
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
restriction fragment length polymorphism
Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡Òýû¡à÷)
restriction fragment length polymorphism,in cystic fibrosis
³¶¼º¼¶À¯Áõ(ÀÇ)¡(Ò¥àõàéë«ñø¡)
restriction fragment length polymorphism analysis
Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
restriction fragment length polymorphism=RFLP
Á¦ÇÑÀýÆí±æÀ̴پ缺
pharmacogenetic polymorphism
¾à¹°À¯ÀüÇÐÀû ´ÙÇü¼º.
polymorphism
´ÙÇü, ´ÙÇüÅÂ
polymorphism
´ÙÇü¼º(Òýû¡à÷), ´ÙÇüÇö»ó(Òýû¡úÞßÚ)
polymorphism
´ÙÇü¼º(Òýúþàõ)
polymorphism
´ÙÇüÁõ
polymorphism
´ÙÇüÁõ(Òýû¡à÷ñø)
polymorphism
´ÙÇü¼ºÁõ
acentric fragment
¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
bone fragment
°ñÆí(Íéø¸), °ñ Á¶°¢.
detached fragment
À¯¸®(°ñ)Æí(ë´ìÆÍéø¸).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½